Immuno-oncology Therapy for Metastatic Triple-Negative Breast Cancer: Emerging Clinical Data and Payer Considerations
Compare drug therapy options and strategies for available and emerging treatments involving immune checkpoint inhibitors (ICIs) for the treatment of metastatic triple-negative breast cancer (mTNBC)
Managed Care Strategies to Support Access to CAR T-Cell Therapy
Examine recent studies for approved and emerging chimeric antigen receptor-modified T cell (CAR) T-cell therapies and the impact of these treatments on the future paradigm of cancer care
A Focus on BTK Inhibitors in B-Cell Malignancies (Part 1 of 2): Foundations of Evidence for Use and Management Strategies for Cardiac and Bleeding Adverse Effects
Outline the efficacy of oral BTK inhibitors across B-cell malignancies including a focus on emerging clinical data
A Focus on BTK Inhibitors in B-Cell Malignancies (Part 2 of 2): Implementing Digital Technology Tools Within Health-Systems to Improve Adherence and Patient Support
This podcast will emphasize the role pharmacists play in improving adherence and patient management through the use of digital and telemedicine technologies in this patient population.